NEWS
Cancer Doctors Urged to Discuss Treatment Costs With Patients
The skyrocketing cost of medical care has been front and center in the current deliberations over how to reform the country’s health care system. A new guidance statement released last week by the American Society of Clinical Oncology (ASCO) tackles one component of the issue head on, urging oncologists to discuss the potential financial costs of care with their patients. These clinician/patient discussions about cost, the guidance statement declares, are “a key component of high-quality care.” Read more > >
Risk of Ovarian Cancer from Hormone Therapy Confirmed
Danish study finds the risk is similar from all types of hormone therapySecond Cervical Cancer Vaccine Protects Against Additional HPV Types
Cervarix under consideration for FDA approvalGenome Scans Provide Clues to Brain Cancer Risk
Researchers find genetic variations linked to risk of brain and other cancersStudy Aims to Improve Common Protein Discovery Method
Sufficient experimental care and technical training can improve reliability and reproducibility, study suggestsDeath Rates for Certain Cancers Remain Higher for African Americans
Disparate rates may be due to a combination of biological and non-biological factorsMayo Clinic Streamlines Development Process for Cancer Trial Protocols
Time to IRB submission fell by 40 percent
COMMENTARY
A Conversation With...Dr. Edith Perez
Dr. Edith Perez is a professor of medicine at the Mayo Clinic in Jacksonville, FL, and the co-principal investigator and North American coordinator for the Adjuvant Lapatinib and/or Trastuzumab Treatment Optimization (ALTTO) clinical trial, an international phase III clinical trial that aims to define the optimal treatment for early stage HER2-positive breast cancer. Read more > >
| Subscribe Now! |
IN DEPTH
A Closer Look: Cutting Calories to Prevent Cancer
Studies in animals and humans show how reduced-calorie diets may modify cancer biomarkers
Featured Clinical Trial: Combining Immunotoxin and Chemotherapy for Pleural Mesothelioma
What is the maximum dose of SS1P immunotoxin that can be administered safely with standard chemotherapy?
Community Update: Making a Difference—Nurses Help Cancer Patients Quit Smoking
Quitting smoking after a diagnosis of cancer is essential for improving survival
UPDATES
FDA Update
- Black Box Warnings Added to Two Smoking Cessation Drugs
- Agency Approves First Maintenance Chemotherapy Agent for NSCLC
Notes
- State-of-the-Science Conference on Ductal Carcinoma In Situ Slated for September
- Chemical Biology Consortium Kick-off Meeting Set for August
- Manifesto on Childhood Cancer Emerges from Meeting in Senegal
- New Issue of CCR Connections Released
- New State Cancer Legislative Database Newsletter and Fact Sheet Now Available
The NCI Cancer Bulletin is produced by the National Cancer Institute (NCI), which was established in 1937. Through basic, clinical, and population-based biomedical research and training, NCI conducts and supports research that will lead to a future in which we can identify the environmental and genetic causes of cancer, prevent cancer before it starts, identify cancers that do develop at the earliest stage, eliminate cancers through innovative treatment interventions, and biologically control those cancers that we cannot eliminate so they become manageable, chronic diseases.
For more information about cancer, call 1-800-4-CANCER or visit http://www.cancer.gov.
NCI Cancer Bulletin staff can be reached at ncicancerbulletin@mail.nih.gov.
